LitCovid-sentences  

PMC:7529504 / 23011-25578 JSONTXT 8 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T147 0-55 Sentence denotes AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
T148 56-143 Sentence denotes The following represents disclosure information provided by authors of this manuscript.
T149 144-212 Sentence denotes All relationships are considered compensated unless otherwise noted.
T150 213-254 Sentence denotes Relationships are self-held unless noted.
T151 255-306 Sentence denotes I = Immediate Family Member, Inst = My Institution.
T152 307-377 Sentence denotes Relationships may not relate to the subject matter of this manuscript.
T153 378-516 Sentence denotes For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/go/site/misc/authors.html.
T154 517-659 Sentence denotes Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
T155 661-680 Sentence denotes Abdul Rahman Jazieh
T156 681-711 Sentence denotes Research Funding: MSD Oncology
T157 712-745 Sentence denotes Travel, Accommodations, Expenses:
T158 746-779 Sentence denotes AstraZeneca, Bristol Myers Squibb
T159 781-800 Sentence denotes Giuseppe Curigliano
T160 801-811 Sentence denotes Honoraria:
T161 812-827 Sentence denotes Ellipses Pharma
T162 828-856 Sentence denotes Consulting or Advisory Role:
T163 857-1040 Sentence denotes Roche, Genentech, Pfizer, Novartis, Eli Lilly, Foundation Medicine, Bristol Myers Squibb, Samsung, AstraZeneca, Daiichi Sankyo, Boehringer Ingelheim, GlaxoSmithKline, Seattle Genetics
T164 1041-1058 Sentence denotes Speakers’ Bureau:
T165 1059-1150 Sentence denotes Roche, Genentech, Novartis, Pfizer, Eli Lilly, Foundation Medicine, Samsung, Daiichi Sankyo
T166 1151-1168 Sentence denotes Research Funding:
T167 1169-1181 Sentence denotes Merck (Inst)
T168 1182-1215 Sentence denotes Travel, Accommodations, Expenses:
T169 1216-1240 Sentence denotes Roche, Genentech, Pfizer
T170 1242-1254 Sentence denotes Evangelia D.
T171 1255-1260 Sentence denotes Razis
T172 1261-1289 Sentence denotes Consulting or Advisory Role:
T173 1290-1331 Sentence denotes AstraZeneca, Bristol Myers Squibb, Pfizer
T174 1332-1349 Sentence denotes Research Funding:
T175 1350-1447 Sentence denotes Novartis, Demo Pharmaceutical, Celldex, PAREXEL, Tesaro, Anabiosis Pharmaceuticals, Radius Health
T176 1448-1481 Sentence denotes Travel, Accommodations, Expenses:
T177 1482-1555 Sentence denotes Genesis Pharmaceuticals, LEO Pharma, Roche, Genekor, Merck, Ipsen, Sanofi
T178 1557-1572 Sentence denotes Hassan Errihani
T179 1573-1601 Sentence denotes Consulting or Advisory Role:
T180 1602-1627 Sentence denotes Pfizer, Roche, MSD, Merck
T181 1628-1645 Sentence denotes Speakers’ Bureau:
T182 1646-1661 Sentence denotes Novartis, Amgen
T183 1662-1679 Sentence denotes Research Funding:
T184 1680-1685 Sentence denotes Roche
T185 1686-1719 Sentence denotes Travel, Accommodations, Expenses:
T186 1720-1753 Sentence denotes Pierre Fabre (Inst), Merck (Inst)
T187 1755-1765 Sentence denotes Roselle B.
T188 1766-1775 Sentence denotes De Guzman
T189 1776-1786 Sentence denotes Honoraria:
T190 1787-1888 Sentence denotes Roche Oncology (Philippines), AstraZeneca, Novartis, Merck Serono, MSD Oncology, Boehringer Ingelheim
T191 1889-1917 Sentence denotes Consulting or Advisory Role:
T192 1918-1992 Sentence denotes Roche, Novartis, Boehringer Ingelheim, AstraZeneca, Centus Biotherapeutics
T193 1993-2026 Sentence denotes Travel, Accommodations, Expenses:
T194 2027-2153 Sentence denotes Hospira (Philippines), Roche (Philippines), Merck Sharp & Dohme, Eisai, Boehringer Ingelheim, AstraZeneca, Eli Lilly, Novartis
T195 2155-2170 Sentence denotes Christian Rolfo
T196 2171-2199 Sentence denotes Consulting or Advisory Role:
T197 2200-2259 Sentence denotes Mylan, Archer Biosciences, Oncompass, Inivata, Merck Serono
T198 2260-2277 Sentence denotes Speakers’ Bureau:
T199 2278-2343 Sentence denotes Novartis, MSD, Boehringer Ingelheim, Guardant Health, AstraZeneca
T200 2344-2361 Sentence denotes Research Funding:
T201 2362-2401 Sentence denotes Lung Cancer Research Foundation, Pfizer
T202 2402-2435 Sentence denotes Travel, Accommodations, Expenses:
T203 2436-2447 Sentence denotes AstraZeneca
T204 2448-2476 Sentence denotes Uncompensated Relationships:
T205 2477-2511 Sentence denotes OncoDNA, Biomark, Guardant Health,
T206 2512-2567 Sentence denotes No other potential conflicts of interest were reported.